Ajanta Pharma P/E Ratio
Ajanta Pharma (AJANTPHARM) P/E ratio is 36.75 (High), EPS (TTM) ₹84.53, current price ₹3020.80 on NSE vs historical average P/E of 21.47 (90.0th percentile) — Very High - High growth expectations or significantly overvalued. Browse Ajanta Pharma annual reports for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
AJANTPHARM P/E Ratio — Valuation Signal & Historical Context
Ajanta Pharma P/E 36.75 vs historical average 21.47, range 9.1–36.89 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Ajanta Pharma share price chart.
- Stock appears overvalued with PE of 36.75, suggesting caution for new investments
- Current PE is 71.2% above historical average
- Trading at discount to sector average PE of 49.11
Ajanta Pharma P/E Ratio Historical Trend
AJANTPHARM annual price-to-earnings ratio — 10 years, EPS and year-end price. Current P/E 36.75 vs historical average 21.47. Analyse AJANTPHARM promoter holding to track promoter, FII and institutional holdings.
AJANTPHARM Historical P/E Ratio — EPS, Year-End Price & Valuation
Ajanta Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 36.89 | 81.18 | ₹2994.35 | NSE | High |
| 2024 | 30.2 | 71.51 | ₹2159.65 | NSE | High |
| 2023 | 20.73 | 58.26 | ₹1207.75 | NSE | Moderate |
| 2022 | 27.31 | 54.05 | ₹1476.15 | NSE | High |
| 2021 | 14.53 | 75.74 | ₹1100.70 | NSE | Low |
| 2020 | 9.1 | 71.65 | ₹652.30 | NSE | Low |
| 2019 | 16.11 | 48.91 | ₹787.80 | NSE | Moderate |
| 2018 | 22.32 | 44.61 | ₹995.85 | NSE | Moderate |
| 2017 | 21.92 | 55.48 | ₹1215.90 | NSE | Moderate |
| 2016 | 15.58 | 57.0 | ₹887.95 | NSE | Moderate |
AJANTPHARM vs Healthcare Peers — P/E Ratio Comparison
Ajanta Pharma P/E 36.75 vs Healthcare average 49.11, median 28.77 — range 0.97–869.57.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |